Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control. | Front Immunol | 2021 | 34084172 | PubTator, text mining | PubMed |
| Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis. | Eur Respir J | 2021 | 34083402 | PubTator, text mining | PubMed |
| Impact of COVID-19 in patients with lymphoid malignancies. | World J Virol | 2021 | 34079692 | PubTator, text mining | PubMed |
| Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States. | J Clin Med | 2021 | 34072345 | PubTator, text mining | PubMed |
| Targeted Approaches to T-Cell Lymphoma. | J Pers Med | 2021 | 34072040 | PubTator, text mining | PubMed |
| Bruton's Tyrosine Kinase Targeting in Multiple Myeloma. | Int J Mol Sci | 2021 | 34071917 | PubTator, text mining | PubMed |
| Nuclear Respiratory Factor-1, a Novel SMAD4 Binding Protein, Represses TGF-β/SMAD4 Signaling by Functioning as a Transcriptional Cofactor. | Int J Mol Sci | 2021 | 34070531 | PubTator, text mining | PubMed |
| Survival-Critical Genes Associated with Copy Number Alterations in Lung Adenocarcinoma. | Cancers (Basel) | 2021 | 34070461 | PubTator, text mining | PubMed |
| Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein-Barr Virus. | Cancers (Basel) | 2021 | 34068598 | PubTator, text mining | PubMed |
| Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy. | Cancers (Basel) | 2021 | 34067257 | PubTator, text mining | PubMed |
| The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia. | J Clin Med | 2021 | 34065833 | PubTator, text mining | PubMed |
| Targeting BTK Signaling in the Microenvironment of Solid Tumors as a Feasible Cancer Therapy Option. | Cancers (Basel) | 2021 | 34063667 | PubTator, text mining | PubMed |
| Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel. | Fam Cancer | 2021 | 34061292 | PubTator, text mining | PubMed |
| Acalabrutinib: A Selective Bruton Tyrosine Kinase Inhibitor for the Treatment of B-Cell Malignancies. | Front Oncol | 2021 | 34055635 | PubTator, text mining | PubMed |
| Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells. | Front Oncol | 2021 | 34055615 | PubTator, text mining | PubMed |
| Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. | Signal Transduct Target Ther | 2021 | 34054126 | PubTator, text mining | PubMed |
| Machine learning enabled identification of potential SARS-CoV-2 3CLpro inhibitors based on fixed molecular fingerprints and Graph-CNN neural representations. | J Biomed Inform | 2021 | 34052441 | PubTator, text mining | PubMed |
| Integrated analysis of long non-coding RNAs (lncRNAs) and mRNA expression profiles identifies lncRNA PRKG1-AS1 playing important roles in skeletal muscle aging. | Aging (Albany NY) | 2021 | 34051073 | PubTator, text mining | PubMed |
| COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development. | Arch Pharm Res | 2021 | 34047940 | PubTator, text mining | PubMed |
| BTK inhibitors, irrespective of ITK inhibition, increase efficacy of a CD19/CD3-bispecific antibody in CLL. | Blood | 2021 | 34046681 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=48